Abstract dotted data landscape in pink and blue

Optimizing DMC Management in Phase III Trials

1 minute read

Published: October 14th, 2025

Navigating multi-therapeutic Phase III studies is complex. From strict blinding protocols to scheduling senior DMC members across multiple time zones, the challenges are significant. Phastar’s tailored approach ensures that every deliverable is managed efficiently, securely, and with the highest statistical rigor. 

Key highlights from our case study: 

  • Full-Spectrum DMC Management: Over 45 blinded and unblinded outputs per meeting, including demographics, disposition, safety, and ad hoc efficacy analyses. 
  • Secure Data Handling: Transitioned from problematic shared folders to compliant sFTP systems, ensuring reliable and secure data sharing. 
  • Process Optimization: Streamlined workflows, facilitated smooth team handovers, and proactively resolved data quality issues. 
  • Stakeholder Integration: Seamlessly collaborated with sponsor and vendor teams, adding value without complexity. 

Complete the form below to read the full case study

Related articles

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

November 16th, 2026 1 minute read

When clinical development programs face quality concerns, resource shortages, or submission risks, sponsors need a pa...

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

November 16th, 2026 1 minute read

When a bioequivalence study fails to meet regulatory criteria, understanding why is critical for successful developme...

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

November 16th, 2026 1 minute read

Data Monitoring Committees play a vital role in safeguarding patient safety and supporting informed decision-making t...